Ezabenlimab (Anti-PDCD1 / PD-1 / CD279)

Synonyms: BI-754091

Ezabenlimab (Anti-PDCD1 / PD-1 / CD279) is a humanized IgG1 monoclonal antibody targeting programmed cell death 1 (PD-1) receptor. It can be used in the treatment of advanced solid tumors. MW :145.48 KD.

Ezabenlimab (Anti-PDCD1 / PD-1 / CD279)

Purity & Quality Control

Choose Selective PD-1/PD-L1 Inhibitors

Name Citation PD-1/PD-L1 interaction PD-1 PD-L1 PD-1/PD-L1 Others
GS-4224 0
INCB086550 0
BMS-1001 0
BMS-1166 5
PD-1/PD-L1 Inhibitor 3 12
BMS-1 12
BMS202 20
CA-170 (AUPM-170)
SR 0987 IL17,RORγt
Spartalizumab (anti-PD-1)
Camrelizumab (anti-PD-1)
AUNP-12
Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Biological Activity

Description Ezabenlimab (Anti-PDCD1 / PD-1 / CD279) is a humanized IgG1 monoclonal antibody targeting programmed cell death 1 (PD-1) receptor. It can be used in the treatment of advanced solid tumors. MW :145.48 KD.

Product Details

CAS No. 2249882-54-8
Isotype Human IgG4SP
Source CHO
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Ezabenlimab (Anti-PDCD1 / PD-1 / CD279) | Ezabenlimab (Anti-PDCD1 / PD-1 / CD279) supplier | purchase Ezabenlimab (Anti-PDCD1 / PD-1 / CD279) | Ezabenlimab (Anti-PDCD1 / PD-1 / CD279) cost | Ezabenlimab (Anti-PDCD1 / PD-1 / CD279) manufacturer | order Ezabenlimab (Anti-PDCD1 / PD-1 / CD279) | Ezabenlimab (Anti-PDCD1 / PD-1 / CD279) distributor